162734-34-1Relevant articles and documents
Orally active inhibitors of stromelysin-1 (MMP-3)
Chapman, Kevin T.,Durette, Philippe L.,Caldwell, Charles G.,Sperow, Kelly M.,Niedzwiecki, Lisa M.,Harrison, Richard K.,Saphos, Cheryl,Christen, Amy J.,Olszewski, Julie M.,Moore, Vernon L.,MacCoss, Malcolm,Hagmann, William K.
, p. 803 - 806 (2007/10/03)
Further development of N-carboxyalkyl dipeptide inhibitors of stromelysin-1 (MMP-3) led to the discovery of C-carboxyalkyl dipeptide analogs with improved oral bioavailability. An in vivo assay of human MMP-3 mediated degradation of a macromolecular substrate in an extravascular space is described and inhibition studies are reported.